表紙
市場調查報告書

合成生物學的全球市場 - 至2025年的預測:寡核苷酸、酵素、合成細胞,遺傳基因合成、生物資訊學

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) - Global Forecast to 2025

出版商 MarketsandMarkets 商品編碼 924764
出版日期 內容資訊 英文 257 Pages
訂單完成後即時交付
價格
合成生物學的全球市場 - 至2025年的預測:寡核苷酸、酵素、合成細胞,遺傳基因合成、生物資訊學 Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) - Global Forecast to 2025
出版日期: 2020年02月07日內容資訊: 英文 257 Pages
簡介

合成生物學市場預測將從2020年的68億美元,擴大到2025年198億美元,在預測期間內預計將以年複合成長率23.9%的速度成長。對合成遺傳基因及合成細胞的需求增加,合成生物學廣泛的用途,DNA定序及合成成本的削減,R&D資金籌措及合成生物學的舉措,市場投資的增加等要素,促進著這個市場成長。可是,有生物安全,生物保全,合成生物學相關的道德疑慮的劇增,可能妨礙這個市場成長。

本報告提供全球合成生物學市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 重要考察

  • 合成生物學市場概要
  • 亞太地區 - 合成生物學市場:各用途
  • 合成生物學市場:各地區的成長機會
  • 合成生物學市場:各地區
  • 合成生物學市場:已開發國家 vs. 發展中國家市場

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 生物學市場:各工具

  • 簡介
  • 寡核苷酸、合成DNA
  • 酵素
  • 基因複製技術套件
  • 合成細胞
  • 底盤有機體
  • zeno核酸 (XNA)

第7章 生物學市場:各技術

  • 簡介
  • 遺傳基因合成
  • 基因工程
  • 定序
  • 生物資訊學
  • 基因複製
  • 特定部位的突然變異誘發
  • 測量、建模
  • 微流體
  • 奈米技術

第8章 生物學市場:各應用

  • 簡介
  • 醫療用
  • 產業用
  • 食品、農業
  • 環境應用

第9章 生物學市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭領導製圖
  • 競爭情形與趨勢

第11章 企業簡介

  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA
  • AGILENT TECHNOLOGIES, INC.
  • NOVOZYMES A/S
  • GINKGO BIOWORKS
  • AMYRIS, INC.
  • INTREXON CORPORATION
  • GENSCRIPT BIOTECH CORPORATION
  • TWIST BIOSCIENCE
  • SYNTHETIC GENOMICS, INC. (SGI)
  • CODEXIS, INC.
  • SYNTHEGO CORPORATION
  • CREATIVE ENZYMES
  • EUROFINS SCIENTIFIC
  • CYRUS BIOTECHNOLOGY, INC.
  • 其他的主要企業
    • ATUM
    • TESELAGEN
    • ARZEDA
    • INTEGRATED DNA TECHNOLOGIES, INC.
    • NEW ENGLAND BIOLABS

第12章 附錄

目錄
Product Code: BT 2910

"The synthetic biology market is projected to grow at a CAGR of 23.9% during the forecast period (2020-2025)."

The synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%. Factors such as the increasing demand for synthetic genes and synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing and synthesizing, increasing R&D funding and initiatives in synthetic biology, and increasing investments in the market are propelling the growth of this market. However, rising biosafety, biosecurity, and ethical concerns related to synthetic biology is likely to hamper the growth of this market.

"The oligonucleotides and synthetic DNA segment is expected to grow at the highest rate during the forecast period."

Based on tools, the market has been segmented into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, chassis organisms, xeno-nucleic acids, and synthetic cells. In 2019, the oligonucleotides and synthetic DNA segment is expected to register the highest CAGR during the forecast period. This can be attributed to factors such as the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications, such as pharmaceuticals, nutraceuticals, personal care, flavors and fragrances, probiotics, green chemicals, and industrial enzymes.

"The genome engineering segment is expected to grow at the highest CAGR during the forecast period."

On the basis of technology, the market is segmented into gene synthesis, genome engineering, cloning, sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology, bioinformatics technologies.

The genome engineering segment is expected to register the highest CAGR during the forecast period due to factors such as the increasing use of engineering technologies for manipulating complex genomes, growing therapeutics development for cancer and other diseases, and the increasing technological advances in CRISPR-toolbox and DNA synthesis technologies.

"The industrial applications segment is expected to grow at the highest CAGR during the forecast period."

Based on application, the synthetic biology market is segmented into medical, industrial, food & agricultural, and environmental applications. The industrial applications segment is expected to grow at the highest CAGR owing to the rising applications of synthetic biology in producing renewable energy, biomaterials & green chemicals, and enzymes.

"The Asia Pacific is projected to witness the highest growth during the forecast period."

The synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the synthetic biology market. However, the APAC region is expected to witness the highest growth during the forecast period owing to the growth in the number of pharmaceutical & biopharmaceutical companies, the increasing number of healthcare & life science facilities, and increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies, growing number of international alliances, heavy funding for synthetic biology research, and strong government support. Furthermore, the increasing focus on the Asia Pacific markets due to their low-cost manufacturing advantage also provides growth opportunities for manufacturers.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-45%, and Tier 3- 20%
  • By Designation: C-level-35%, Director-level-45%, and Others-20%
  • By Region: North America-45%, Europe-30%, Asia Pacific-20%, Latin America-3%, and the Middle East & Africa-2%

The prominent players in the synthetic biology market are: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris, Inc. (US), Intrexon Corporation (US), GenScript Biotech Corporation (China), Twist Bioscience (US), Synthetic Genomics, Inc. (US), Codexis, Inc. (US), Synthego Corporation (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg), Cyrus Biotechnology Inc. (US), ATUM (US), TeselaGen (US), Arzeda (US), Integrated DNA Technologies, Inc. (US), and New England Biolabs (US).

Research Coverage:

The report analyzes the market for various synthetic biology market and their adoption patterns. It aims at estimating the market size and future growth potential of the synthetic biology market and its subsegments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the synthetic biology market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the synthetic biology market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the synthetic biology market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION & SCOPE
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 STAKEHOLDERS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 DATA TRIANGULATION APPROACH
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 SYNTHETIC BIOLOGY MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION
  • 4.3 SYNTHETIC BIOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 SYNTHETIC BIOLOGY MARKET, BY REGION (2018-2025)
  • 4.5 SYNTHETIC BIOLOGY MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Wide range of applications of synthetic biology
      • 5.2.1.2 Rising R&D funding and growing initiatives in synthetic biology
      • 5.2.1.3 Declining cost of DNA sequencing and synthesizing
      • 5.2.1.4 Increasing investments in the market
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Biosafety, biosecurity, and ethical concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising need for fuel alternatives
      • 5.2.3.2 Increasing demand for protein therapeutics and personalized medicine
      • 5.2.3.3 Increasing research in synthetic drugs and vaccines
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Standardization of biological parts

6 SYNTHETIC BIOLOGY MARKET, BY TOOL

  • 6.1 INTRODUCTION
  • 6.2 OLIGONUCLEOTIDES & SYNTHETIC DNA
    • 6.2.1 OLIGONUCLEOTIDES AND SYNTHETIC DNA TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • 6.3 ENZYMES
    • 6.3.1 DEVELOPMENT OF ENZYMES HAS HELPED IN EVOLVING NEW THERAPIES FOR A RANGE OF DISEASES
  • 6.4 CLONING TECHNOLOGY KITS
    • 6.4.1 NEED FOR THE CREATION OF ARTIFICIAL DNA ALONG WITH THEIR ASSEMBLY IS DRIVING THE GROWTH OF THE SEGMENT
  • 6.5 SYNTHETIC CELLS
    • 6.5.1 SYNTHETIC CELLS WILL ALLOW TAILORING BIOLOGICS AND ITS ADOPTION IS EXPECTED TO GROW IN THE COMING YEARS
  • 6.6 CHASSIS ORGANISMS
    • 6.6.1 INCREASING DEMAND FOR FOSSIL FUELS IS LIKELY TO PROPEL THE DEMAND FOR CHASSIS ORGANISMS
  • 6.7 XENO-NUCLEIC ACIDS
    • 6.7.1 XNAS ARE INCREASINGLY RESEARCHED WITH THE GROWING DEMAND FOR BREAKTHROUGH MEDICINE

7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 GENE SYNTHESIS
    • 7.2.1 GENE SYNTHESIS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • 7.3 GENOME ENGINEERING
    • 7.3.1 INCREASING DEMAND FOR SYNTHETIC DNA AND GENES IS EXPECTED TO DRIVE MARKET GROWTH
  • 7.4 SEQUENCING
    • 7.4.1 NGS TECHNOLOGY IS RAPIDLY BECOMING AN INDISPENSABLE AND UNIVERSAL TOOL FOR BIOLOGICAL RESEARCH
  • 7.5 BIOINFORMATICS
    • 7.5.1 USE OF BIOINFORMATICS TECHNOLOGIES IS INCREASING WITH THE RISING NEED FOR DATA MANAGEMENT AND CURATION
  • 7.6 CLONING
    • 7.6.1 CLONING AIDS IN BUILDING NEW GENETIC MODULES/PATHWAYS, ENABLING RAPID ADVANCES IN RESEARCH ACROSS VARIOUS INDUSTRIES
  • 7.7 SITE-DIRECTED MUTAGENESIS
    • 7.7.1 WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES IS DRIVING THIS SEGMENT
  • 7.8 MEASUREMENT & MODELING
    • 7.8.1 COMPUTATIONAL MODELING IS AIDING THE GROWTH OF THE SEGMENT DURING THE FORECAST PERIOD
  • 7.9 MICROFLUIDICS
    • 7.9.1 DROPLET MICROFLUIDICS IS GAINING WIDE RECOGNITION IN THE FIELD OF SYNTHETIC BIOLOGY
  • 7.10 NANOTECHNOLOGY
    • 7.10.1 CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGIES AID IN BUILDING COMPLEX BODIES

8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 MEDICAL APPLICATIONS
    • 8.2.1 PHARMACEUTICALS
      • 8.2.1.1 In 2019, the pharmaceuticals segment accounted for the largest share of the medical applications market
    • 8.2.2 DRUG DISCOVERY AND THERAPEUTICS
      • 8.2.2.1 Cancer detection & diagnostics
        • 8.2.2.1.1 With rising investments for cancer research, the market for synthetic biology is expected to grow for this segment
      • 8.2.2.2 Other drug discovery and therapeutic applications
    • 8.2.3 ARTIFICIAL TISSUE & TISSUE REGENERATION
      • 8.2.3.1 Bio-synthesis
        • 8.2.3.1.1 Bio-synthesis is dominating the market with its increasing adoption in creating artificial genomes
      • 8.2.3.2 Stem cell regulation
        • 8.2.3.2.1 Use of synthetic biology in stem cell regeneration and reprogramming somatic cells is expected to drive market growth
      • 8.2.3.3 Other artificial tissue and tissue regeneration applications
  • 8.3 INDUSTRIAL APPLICATIONS
    • 8.3.1 BIOFUEL AND RENEWABLE ENERGY
      • 8.3.1.1 Advantages of using genetically engineered organisms for the synthetic production of biofuels is driving market growth
    • 8.3.2 INDUSTRIAL ENZYMES
      • 8.3.2.1 Textile industry
        • 8.3.2.1.1 Synthetic biology is being applied in the textile industry to replace traditional raw materials
      • 8.3.2.2 Paper industry
        • 8.3.2.2.1 Enzymes are being increasingly used in the pulp and paper industry
      • 8.3.2.3 Other industries
    • 8.3.3 BIOMATERIALS & GREEN CHEMICALS
      • 8.3.3.1 Silk-based proteins are a type of biomaterial prepared through synthetic biology
  • 8.4 FOOD & AGRICULTURE
    • 8.4.1 SYNTHETIC BIOLOGY TECHNIQUES ARE APPLIED IN THE FOOD AND AGRICULTURE INDUSTRY TO PRODUCE METABOLITES, HEALTH PRODUCTS, AND PROCESSING AIDS
  • 8.5 ENVIRONMENTAL APPLICATIONS
    • 8.5.1 BIOREMEDIATION
      • 8.5.1.1 Owing to the growing severity of environmental problems, it has become necessary to develop cost-effective, on-site methods for environmental monitoring and bioremediation
    • 8.5.2 BIOSENSING
      • 8.5.2.1 Biosensor applications commonly make use of microalgae owing to their high reproductive rates and ease of culturing due to their microscopic size

9 SYNTHETIC BIOLOGY MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American synthetic biology market
    • 9.2.2 CANADA
      • 9.2.2.1 Strong research infrastructure and availability of funding will support market growth
  • 9.3 EUROPE
    • 9.3.1 UK
      • 9.3.1.1 The UK holds the largest share of the European market
    • 9.3.2 GERMANY
      • 9.3.2.1 The rapidly growing pharmaceutical market is expected to drive market growth
    • 9.3.3 FRANCE
      • 9.3.3.1 Research across all industries is strongly supported by the government
    • 9.3.4 DENMARK
      • 9.3.4.1 Denmark has the third-largest commercial drug-development pipeline in Europe
    • 9.3.5 SWITZERLAND
      • 9.3.5.1 Market growth is primarily driven by the well-established pharmaceutical & biotechnology industry in the country
    • 9.3.6 SPAIN
      • 9.3.6.1 Spain has a well-established network of research centers, universities, and hospitals, which form an ideal environment for research
    • 9.3.7 ITALY
      • 9.3.7.1 Growth in this market is mainly driven by increasing life science R&D in the country, funded by both public and private organizations
    • 9.3.8 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 Large number of research initiatives towards the development of precision medicine supporting market growth
    • 9.4.2 CHINA
      • 9.4.2.1 Growth in R&D to enhance the technological capabilities in the country, thereby driving the demand for high-quality research tools
    • 9.4.3 AUSTRALIA
      • 9.4.3.1 Increasing focus of the healthcare system on precision medicine to offer significant growth opportunities
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing pharma R&D and government funding in the biotechnology industry are the major factors driving market growth
    • 9.4.5 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 STRONG PHARMACEUTICAL INDUSTRY IN THE REGION TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 INCREASING PARTNERSHIPS AMONG GLOBAL PLAYERS WITH GOVERNMENT ORGANIZATIONS IN THE REGION TO SUPPORT GROWTH

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANALYSIS
    • 10.2.1 SYNTHETIC BIOLOGY MARKET, BY KEY PLAYERS, 2018
  • 10.3 COMPETITIVE LEADERSHIP MAPPING
    • 10.3.1 VISIONARY LEADERS
    • 10.3.2 INNOVATORS
    • 10.3.3 DYNAMIC DIFFERENTIATORS
    • 10.3.4 EMERGING COMPANIES
  • 10.4 COMPETITIVE SITUATION AND TRENDS
    • 10.4.1 PRODUCT LAUNCHES
    • 10.4.2 EXPANSIONS
    • 10.4.3 ACQUISITIONS
    • 10.4.4 OTHER STRATEGIES

11 COMPANY PROFILES

(Business Overview, Products/Services Offered, Recent Developments, SWOT Analysis, and MnM View)*

  • 11.1 THERMO FISHER SCIENTIFIC, INC.
  • 11.2 MERCK KGAA
  • 11.3 AGILENT TECHNOLOGIES, INC.
  • 11.4 NOVOZYMES A/S
  • 11.5 GINKGO BIOWORKS
  • 11.6 AMYRIS, INC.
  • 11.7 INTREXON CORPORATION
  • 11.8 GENSCRIPT BIOTECH CORPORATION
  • 11.9 TWIST BIOSCIENCE
  • 11.10 SYNTHETIC GENOMICS, INC. (SGI)
  • 11.11 CODEXIS, INC.
  • 11.12 SYNTHEGO CORPORATION
  • 11.13 CREATIVE ENZYMES
  • 11.14 EUROFINS SCIENTIFIC
  • 11.15 CYRUS BIOTECHNOLOGY, INC.
  • Business Overview, Products Offered, Recent Developments, SWOT Analysis, and MnM View might not be captured in case of unlisted companies.
  • 11.16 OTHER MAJOR COMPANIES
    • 11.16.1 ATUM
    • 11.16.2 TESELAGEN
    • 11.16.3 ARZEDA
    • 11.16.4 INTEGRATED DNA TECHNOLOGIES, INC.
    • 11.16.5 NEW ENGLAND BIOLABS

12 APPENDIX

  • 12.1 INSIGHTS OF INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 2: SYNTHETIC BIOLOGY MARKET FOR TOOLS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
  • TABLE 3: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES & SYNTHETIC DNA, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 4: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 5: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 6: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 7: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 8: SYNTHETIC BIOLOGY MARKET FOR XENO-NUCLEIC ACIDS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 9: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 10: SYNTHETIC BIOLOGY MARKET FOR TECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 11: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 12: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 13: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 14: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 15: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 16: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
  • TABLE 17: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT & MODELING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 18: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 19: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 20: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 21: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 22: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 23: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 24: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 25: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 26: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION & DIAGNOSTICS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 27: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 28: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 29: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 30: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 31: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 32: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 33: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 34: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 35: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 36: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2018-2025 (USD MILLION)
  • TABLE 37: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 38: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 39: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 40: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 41: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 42: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURE, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 43: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 44: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 45: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 46: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 47: SYNTHETIC BIOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 48: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 49: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 50: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 51: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 52: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 53: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 54: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 55: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 56: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 57: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 58: US: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 59: US: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 60: US: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 61: US: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 62: US: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 63: US: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 64: US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 65: US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 66: US: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 67: CANADA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 68: CANADA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 69: CANADA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 70: CANADA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 71: CANADA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 72: CANADA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 73: CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 74: CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 75: CANADA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 76: EUROPE: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 77: EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 78: EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 79: EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 80: EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 81: EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 82: EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 83: EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 84: EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 85: EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 86: UK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 87: UK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 88: UK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 89: UK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 90: UK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 91: UK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 92: UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 93: UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 94: UK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 95: GERMANY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 96: GERMANY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 97: GERMANY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 98: GERMANY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 99: GERMANY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 100: GERMANY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 101: GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 102: GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 103: GERMANY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 104: FRANCE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 105: FRANCE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 106: FRANCE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 107: FRANCE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 108: FRANCE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 109: FRANCE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 110: FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 111: FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 112: FRANCE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 113: DENMARK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 114: DENMARK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 115: DENMARK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 116: DENMARK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 117: DENMARK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 118: DENMARK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 119: DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 120: DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 121: DENMARK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 122: SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 123: SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 124: SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 125: SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 126: SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 127: SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 128: SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 129: SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 130: SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 131: SPAIN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 132: SPAIN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 133: SPAIN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 134: SPAIN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 135: SPAIN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 136: SPAIN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 137: SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 138: SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2018-2025 (USD MILLION)
  • TABLE 139: SPAIN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 140: ITALY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 141: ITALY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 142: ITALY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 143: ITALY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 144: ITALY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 145: ITALY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 146: ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 147: ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 148: ITALY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 149: ROE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 150: ROE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 151: ROE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 152: ROE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 153: ROE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 154: ROE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 155: ROE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 156: ROE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 157: ROE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 158: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 159: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 160: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 161: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 162: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 163: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 164: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 165: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 166: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 167: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 168: JAPAN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 169: JAPAN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 170: JAPAN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 171: JAPAN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 172: JAPAN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 173: JAPAN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 174: JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 175: JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 176: JAPAN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 177: CHINA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 178: CHINA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 179: CHINA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 180: CHINA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 181: CHINA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 182: CHINA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 183: CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 184: CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 185: CHINA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 186: AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 187: AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 188: AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 189: AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 190: AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 191: AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 192: AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 193: AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 194: AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 195: INDIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 196: INDIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 197: INDIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 198: INDIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 199: INDIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 200: INDIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 201: INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 202: INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 203: INDIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 204: ROAPAC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 205: ROAPAC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 206: ROAPAC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 207: ROAPAC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 208: ROAPAC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 209: ROAPAC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 210: ROAPAC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 211: ROAPAC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 212: ROAPAC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 213: LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 214: LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 215: LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 216: LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 217: LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 218: LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 219: LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 220: LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 221: LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 222: MEA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2018-2025 (USD MILLION)
  • TABLE 223: MEA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • TABLE 224: MEA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 225: MEA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 226: MEA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY & THERAPEUTICS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 227: MEA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE & TISSUE REGENERATION, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 228: MEA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 229: MEA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 230: MEA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 231: PRODUCT LAUNCHES, 2017-2019
  • TABLE 232: EXPANSIONS, 2017-2019
  • TABLE 233: ACQUISITIONS, 2017-2019
  • TABLE 234: OTHER STRATEGIES, 2017-2019

LIST OF FIGURES

  • FIGURE 1: SYNTHETIC BIOLOGY MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
  • FIGURE 4: MARKET SIZE APPROACH
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020 VS. 2025 (USD MILLION)
  • FIGURE 8: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
  • FIGURE 9: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  • FIGURE 10: GEOGRAPHIC ANALYSIS: SYNTHETIC BIOLOGY MARKET
  • FIGURE 11: WIDE RANGE OF APPLICATIONS OF SYNTHETIC BIOLOGY FORMS THE MAJOR FACTOR DRIVING MARKET GROWTH
  • FIGURE 12: MEDICAL APPLICATIONS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC SYNTHETIC BIOLOGY MARKET IN 2019
  • FIGURE 13: CHINA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: NORTH AMERICA WILL CONTINUE TO DOMINATE THE SYNTHETIC BIOLOGY MARKET TILL 2025
  • FIGURE 15: DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 16: SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: REDUCTION IN COST PER RAW MEGABASE OF DNA SEQUENCING (USD) (2009-2019)
  • FIGURE 18: COST OF SYNTHETIC GENES (2009-2019)
  • FIGURE 19: FUNDING FOR SYNTHETIC BIOLOGY COMPANIES (2009-2018)
  • FIGURE 20: OLIGONUCLEOTIDES & SYNTHETIC DNA SEGMENT TO DOMINATE THE SYNTHETIC BIOLOGY TOOLS MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: GENE SYNTHESIS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020 VS. 2025
  • FIGURE 23: SYNTHETIC BIOLOGY MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 24: NORTH AMERICA: SYNTHETIC BIOLOGY MARKET SNAPSHOT
  • FIGURE 25: EUROPE: SYNTHETIC BIOLOGY MARKET SNAPSHOT
  • FIGURE 26: ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET SNAPSHOT
  • FIGURE 27: KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM J ANUARY 2017 TO DECEMBER 2019
  • FIGURE 28: COMPANY SHARE ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 29: SYNTHETIC BIOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
  • FIGURE 30: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 31: MERCK KGAA: COMPANY SNAPSHOT (2018)
  • FIGURE 32: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
  • FIGURE 33: NOVOZYMES A/S: COMPANY SNAPSHOT (2018)
  • FIGURE 34: AMYRIS, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 35: INTREXON CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 36: GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 37: CODEXIS, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 38: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2018)